Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Next revisionBoth sides next revision | ||
content:alpha-feto_protein_serum [2020/02/16 20:46] – icna | content:alpha-feto_protein_serum [2020/02/17 19:42] – [Alpha-Feto protein, serum] icna | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== Alpha-Feto protein, serum ====== | ====== Alpha-Feto protein, serum ====== | ||
- | <alert type=" | ||
{{tag> | {{tag> | ||
==== Indications ==== | ==== Indications ==== | ||
* any type of movement disorder in early childhood, cerebellar ataxias, [[oculomotor apraxia]](saccadic impairment) | * any type of movement disorder in early childhood, cerebellar ataxias, [[oculomotor apraxia]](saccadic impairment) | ||
==== Notes ==== | ==== Notes ==== | ||
- | Alpha-fetoprotein (AFP) is present in fetal serum in concentrations up to 5,000,000 μg/l Postnatally AFP gene expression is turned down with a subsequent fall of the serum concentrations to 'adult values' | + | Alpha-fetoprotein (AFP) is present in fetal serum in concentrations up to 5,000,000 μg/l. Postnatally |
- | Increased serum AFP is a biomarker for [[Ataxia Telangiectasia]], | + | Increased serum AFP is a biomarker for [[Ataxia Telangiectasia]], |
* **Classic Ataxia Telangiectasia** | * **Classic Ataxia Telangiectasia** | ||
Line 32: | Line 31: | ||
* raised serum/csf lactate | * raised serum/csf lactate | ||
- | ==== References ==== | + | CSF AFP levels in normal infants also decline with gestational age in proportion to levels of AFP in serum[(: |
- | ~~REFNOTES~~ | + | * median 61 kIU/L (5th-95th centile: 2-889 kIU/L) in infants -69 to 31 days old |
+ | * median 1.2 kIU/L (5th-95th centile: 0.1-12.5 kIU/L) in infants 32 to 110 days old |